103 related articles for article (PubMed ID: 10219538)
1. New controlled-release ibuprofen tablets.
Palmieri GF; Lovato D; Martelli S
Drug Dev Ind Pharm; 1999 May; 25(5):671-7. PubMed ID: 10219538
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
3. ["Non-solvent shock agglomeration"--technology of a new alternative method for sustained release of ibuprofen. 5. Production and evaluation of retard formulations].
Möller T; Korsatko W
Pharmazie; 2000 Feb; 55(2):114-9. PubMed ID: 10723769
[TBL] [Abstract][Full Text] [Related]
4. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
5. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
6. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
7. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
8. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
Pabari RM; Ramtoola Z
Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
[TBL] [Abstract][Full Text] [Related]
9. Formulation of a extended release tablet containing dexibuprofen.
Yi HG; Chi MH; Kim YI; Woo JS; Park ES
Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
[TBL] [Abstract][Full Text] [Related]
10. Properties of tablets containing granulations of ibuprofen and an acrylic copolymer prepared by thermal processes.
Kidokoro M; Shah NH; Malick AW; Infeld MH; McGinity JW
Pharm Dev Technol; 2001; 6(2):263-75. PubMed ID: 11417001
[TBL] [Abstract][Full Text] [Related]
11. ["Non-solvent shock agglomeration technology" as a new alternative method for work on ibuprofen. 4. Production and evaluation of quick release forms].
Möller T; Korsatko W
Pharmazie; 2000 Jan; 55(1):53-8. PubMed ID: 10683872
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation.
Mumuni M; Kenechukwu FC; Chime SA; Ogbonna JD; Mora AT
Drug Deliv; 2014 Jun; 21(4):315-9. PubMed ID: 24191762
[TBL] [Abstract][Full Text] [Related]
13. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
Salunkhe KS; Kulkarni MV
Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
[TBL] [Abstract][Full Text] [Related]
14. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
Dille MJ; Hattrem MN; Draget KI
Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
[TBL] [Abstract][Full Text] [Related]
15. Influence of ibuprofen as a solid-state plasticizer in Eudragit RS 30 D on the physicochemical properties of coated beads.
Wu C; McGinity JW
AAPS PharmSciTech; 2001 Nov; 2(4):24. PubMed ID: 14727861
[TBL] [Abstract][Full Text] [Related]
16. Ibuprofen agglomerates preparation by phase separation.
Jbilou M; Ettabia A; Guyot-Hermann AM; Guyot JC
Drug Dev Ind Pharm; 1999 Mar; 25(3):297-305. PubMed ID: 10071822
[TBL] [Abstract][Full Text] [Related]
17. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note.
Gohel M; Parikh R; Brahmbhatt B; Shah A
AAPS PharmSciTech; 2007 Feb; 8(1):13. PubMed ID: 17408213
[TBL] [Abstract][Full Text] [Related]
18. Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen.
Lopes CM; Lobo JM; Pinto JF; Costa PC
AAPS PharmSciTech; 2007 Sep; 8(3):E76. PubMed ID: 17915826
[TBL] [Abstract][Full Text] [Related]
19. Formulation studies on ibuprofen sodium-cationic dextran conjugate: effect on tableting and dissolution characteristics of ibuprofen.
Abioye AO; Kola-Mustapha A
Drug Dev Ind Pharm; 2016 Jan; 42(1):39-59. PubMed ID: 25826253
[TBL] [Abstract][Full Text] [Related]
20. Accelerated degradation of ibuprofen in tablets.
Cory WC; Harris C; Martinez S
Pharm Dev Technol; 2010 Dec; 15(6):636-43. PubMed ID: 19941407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
